The emerging role of adipocytokines as inflammatory mediators in inflammatory bowel disease.
about
Frequency and significance of the novel single nucleotide missense polymorphism Val109Asp in the human gene encoding omentin in Caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel diseasesThe role of physical exercise in inflammatory bowel diseaseAdipokines and the role of visceral adipose tissue in inflammatory bowel diseaseDefective apoptosis in intestinal and mesenteric adipose tissue of Crohn's disease patientsThe Impact of Obesity on the Clinical Course of Inflammatory Bowel Disease: A Meta-Analysis.The Role of the Mesentery in Crohn's Disease: The Contributions of Nerves, Vessels, Lymphatics, and Fat to the Pathogenesis and Disease Course.Gingival crevicular fluid and serum levels of resistin in obese and non-obese subjects with and without periodontitis and association with single nucleotide polymorphism at -420Leptin's metabolic and immune functions can be uncoupled at the ligand/receptor interaction levelMetabolic syndrome frequency in inflammatory bowel diseases.Differential effects of energy balance on experimentally-induced colitis.Melanin-concentrating hormone as a mediator of intestinal inflammation.Retinol Binding Protein 4 in children with Inflammatory Bowel Disease: a negative correlation with the disease activity.Predictors of vitamin D deficiency in inflammatory bowel disease and health: A Mississippi perspective.Leptin-activity blockers: development and potential use in experimental biology and medicine.The bone and fat connection in inflammatory bowel diseases.Mesenteric panniculitis: an update.Novel multiplex method to assess insulin, leptin and adiponectin regulation of inflammatory cytokines associated with colon cancer.Plasma ghrelin and leptin in patients with inflammatory bowel disease and its association with nutritional status.Obesity in Inflammatory Bowel Disease: A Marker of Less Severe Disease.The body composition profile is associated with response to anti-TNF therapy in Crohn's disease and may offer an alternative dosing paradigm.Serum levels and mesenteric fat tissue expression of adiponectin and leptin in patients with Crohn's disease.
P2860
Q24670337-90A1EA7D-CB99-4BE0-B5F8-C39AC0B24C83Q26865777-B889B258-3059-4880-8B97-47A6A8EBA836Q28070229-845FE6AE-5F5D-47EB-B1E5-D0E4FD514CAFQ33699974-7B3B031A-1A01-4582-B13D-59ACC5FC0293Q33772167-72913137-94B7-4E3A-AECF-9F5279F6D637Q34526079-FAC9B9A3-3969-4E09-89B0-EFB99DCDF93BQ34553317-3F6205DC-746C-442C-97D2-C31A3C6C95DAQ34947204-3D815BC2-12C7-4C3A-A6A2-34EF1397D92BQ35564312-EAD11E08-4346-452D-862C-500AAD27C09EQ35761692-FA3742F7-46AE-46EC-AD58-626F89E22147Q36802510-E08CF978-F2D4-4F98-A624-760D6E0F3C8DQ37083027-417A18C2-68AC-4DD0-A925-61927D606CFCQ37625213-4DDE5213-9D19-49B8-8121-DB1D7612CF1AQ38151768-373AB284-EE98-4065-BFC7-8B4FDFC929F6Q38225220-B8886492-00ED-43AC-85DD-10039C1CB6CEQ38249074-61AC4F7E-6ED3-45F2-9E04-10ECB5DD8D7DQ39423635-78407C91-DC4D-44D2-8278-89C59C75A359Q42203617-893D77D0-627F-4519-93A2-287C19C69BF0Q44209841-D734EE91-635B-414A-8163-AB816775A9AEQ48021336-83E0ADE0-F15A-4B89-9285-3EBEA0BE59EAQ50899263-366BA39A-5FC1-4742-BC68-5B21867A84F3
P2860
The emerging role of adipocytokines as inflammatory mediators in inflammatory bowel disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The emerging role of adipocyto ...... in inflammatory bowel disease.
@ast
The emerging role of adipocyto ...... in inflammatory bowel disease.
@en
type
label
The emerging role of adipocyto ...... in inflammatory bowel disease.
@ast
The emerging role of adipocyto ...... in inflammatory bowel disease.
@en
prefLabel
The emerging role of adipocyto ...... in inflammatory bowel disease.
@ast
The emerging role of adipocyto ...... in inflammatory bowel disease.
@en
P2860
P1476
The emerging role of adipocyto ...... in inflammatory bowel disease
@en
P2093
Elias A Kouroumalis
P2860
P304
P356
10.1097/01.MIB.0000178915.54264.8F
P577
2005-09-01T00:00:00Z